系统性红斑狼疮黏膜皮肤疾病活动与损伤累积:亚太狼疮协作纵向队列研究分析
基于亚太狼疮协作队列2013-2021年数据,4,102例SLE患者中36.5%出现黏膜皮肤活动(MC-A),16.6%为持续性MC-A,4.3%累积黏膜皮肤损伤(MC-D)。MC-A与血清学及系统性疾病活动负担相关,持续性MC-A增加MC-D风险,所有黏膜皮肤表现均与更差健康相关生活质量(HRQoL)相关。
要点
- SLE患者中36.5%出现MC-A,16.6%为持续性MC-A,4.3%累积MC-D。
- 持续性MC-A与MC-D风险增加相关,强调早期有效治疗的重要性。
- 所有黏膜皮肤表现均与更差HRQoL相关,吸烟是可改变的MC-A相关因素。
核心结论
- 所有黏膜皮肤表现均与更差HRQoL相关。
- MC-A与SLE血清学及系统性疾病活动负担相关。
- 持续性MC-A与MC-D风险增加相关,强调早期有效治疗的重要性。
- MC-A和MC-D在White患者中更常见,提示 ethnic 和环境影响因素。
- 吸烟是MC-A潜在可改变的相关因素。
研究设计与样本
- 分析亚太狼疮协作队列2013-2021年数据。
- MC-A项目(皮疹、脱发、黏膜溃疡)由SLE疾病活动指数2000定义,持续至少6个月为持续性。
- MC-D项目(慢性皮肤溃疡、瘢痕性脱发、皮肤/脂膜瘢痕)由SLICC/ACR损伤指数定义。
- HRQoL采用36项简短健康调查(SF-36)测量。
- 采用多变量逻辑广义估计方程模型确定每次访视MC-A的相关因素,采用时变协变量生存模型确定MC-D的预测因素。
主要发现
- 中位随访2.5(四分位距1.0-5.1)年,4,102例患者中1,499例(36.5%)出现MC-A(皮疹n=1,055,脱发n=731,黏膜溃疡n=352),3,655例中606例(16.6%)为持续性MC-A。
- 持续性MC-A患者平均精神成分评分(42.6 vs 44.8;P=0.014)和身体成分评分(41.1 vs 46.1;P<0.001)更差。
- White人种、吸烟、血清学活动、血管炎、肌炎、浆膜炎、肾炎及神经/精神特征为MC-A的相关因素。
- 3,647例患者中157例(4.3%)累积MC-D(皮肤/脂膜瘢痕n=53,脱发n=98,溃疡n=30)。
- MC-D患者平均身体成分评分更差(39.8 vs 46.0,P=0.001),且更可能为White人种并伴有持续性MC-A。
临床怎么用
- 对SLE患者应早期识别并有效治疗黏膜皮肤活动,以降低持续性MC-A及后续MC-D风险。
- 吸烟是MC-A可改变的相关因素,临床应加强戒烟干预。
- White人种患者MC-A和MC-D风险更高,需关注 ethnic 和环境因素对疾病表现的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This research article aims to describe the prevalence, associations, and health-related quality of life (HRQoL) impact of mucocutaneous features of systemic lupus erythematosus (SLE). METHODS: Data from the Asia-Pacific Lupus Collaboration cohort were analyzed (2013-2021). Mucocutaneous activity (MC-A) items were rash, alopecia, and mucosal ulcers; were defined by the Systemic Lupus Erythematosus Disease Activity Index 2000; and were persistent if present for at least six months. Mucocutaneous damage (MC-D) items were chronic skin ulceration, scarring alopecia, and skin/panniculum scarring and were defined by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index. HRQoL was measured by 36-Item Short Form Health Survey (SF-36) surveys. Multivariate logistic generalized estimating equation models were used to determine correlates of MC-A at each visit. Time-varying covariate survival models were used to determine predictors of MC-D. RESULTS: During a median of 2.5 (interquartile range 1.0-5.1) years' follow-up, 1,499 of 4,102 patients (36.5%) had MC-A (rash n = 1,055, alopecia n = 731, mucosal ulcers n = 352) and 606 of 3,655 patients (16.6%) had persistent MC-A. These patients were more likely to record worse mean mental (42.6 vs 44.8; P = 0.014) and physical component (41.1 vs 46.1; P < 0.001) SF-36 scores. Being White, smoking, serologic activity, vasculitis, myositis, serositis, nephritis, and neurologic/psychiatric features were correlates of MC-A. Of 3,647 patients, 157 (4.3%) accrued MC-D (skin/panniculum scarring n = 53, alopecia n = 98, ulceration n = 30). These patients had worse mean physical component (39.8 vs 46.0, P = 0.001) SF-36 scores and were more likely to be White with persistent MC-A. CONCLUSION: All mucocutaneous manifestations were associated with worse HRQoL. MC-A correlated with serologic and systemic disease activity burden in SLE. Persistent MC-A was associated with increased risk of MC-D, emphasizing the importance of early and effective treatment. Both MC-A and MC-D were more likely in White patients, suggesting ethnic and environmental impacts. Smoking was a potentially modifiable correlate of MC-A.
引用
- Saracino AM, Hao Y, Hansen D, et al. Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia-Pacific Lupus Collaboration Longitudinal Cohort Study. Arthritis Care Res (Hoboken). 2026. PMID: 41940438. doi:10.1002/acr.80050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。